Bone Marrow Transplantation

Top Story

Hypomethylating agents alone show poor long-term OS for high-risk myelodysplastic syndrome

April 10, 2018
Commentary

Changing the paradigm of cytomegalovirus management among HSCT patients

HemOnc Today, April 10, 2018
Roy F. Chemaly, MD, MPH, FACP, FIDSA
Cytomegalovirus infection occurs among approximately 40% of cytomegalovirus-seropositive patients within the first 100 days following hematopoietic stem cell transplant…
Feature

ASH president: Society ‘has tremendous capacity’ to advance, improve care around the world

April 2, 2018
Alexis A. Thompson, MD, MPH, took over as ASH president in January. Thompson — head of the hematology section in the division of hematology, oncology and…
Meeting NewsPerspective

Diverse gut microbiota may improve OS in allogeneic hematopoietic cell transplantation

March 27, 2018
SALT LAKE CITY — Diversity of gut microbiota at the time of neutrophil engraftment in allogeneic hematopoietic stem cell transplantation appeared associated with…
More Headlines »
CME ABIM MOC

Ace the Case: A 70-Year-Old Woman with Cough and a Lung Mass

There is no commercial support for this activity.

This “Ace the Case” activity will discuss the diagnosis and management of a 70-year-old woman with cough…
More »
Video
Meeting News

VIDEO: Letermovir CMV prophylaxis offers survival benefit in hematopoietic cell transplant patients

October 14, 2017
More »
Resource Centers
American Association for Cancer Research Annual Meeting

American Association for Cancer Research Annual Meeting

CME

Applying Advances with Checkpoint Inhibitors in Thoracic Oncology

This activity is supported by an educational grant from Merck & Co., Inc.

Lung cancer is a leading cause of cancer-related deaths worldwide. It is estimated that 222,500 new cases of lung…
More »